Normal serum prostate specific antigen levels in men in Yasuj province, Islamic Republic of Iran

Eastern Mediterranean Health Journal

Volumn 13, Issue 5, 2007, Pages 1190-1194

  Mehrabi, S ^a   Ghafarian Shirhzi, H R ^a   Rasti, M ^a  

^a YASUJ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; EUROPE; HUMAN; IMMUNOASSAY; IRAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PROSTATE CANCER; PROSTATECTOMY; PROSTATITIS; RACE DIFFERENCE; TRANSURETHRAL RESECTION; UNITED STATES; URINARY TRACT INFECTION;

EID: 37849032040     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2007.13.5.1190     Document Type: Article

References (14)

1. Ballentine H, Partin AW. Diagnosis and staging of prostate cancer. In: Walsh PC et al., eds. Campbell urology, 8th ed. Philadelphia, WB Saunders Company, 2002:3055-79.
2. Stamey TA et al. The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years? Journal of urology, 2004, 172:1297-301.
3. Antonopoulos IM et al. Racial differences in prostate cancer prevalence. International braz j urol: official journal of the Brazilian Society of Urology, 2002, 28:214-20.
4. Moul JW et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. Journal of the American Medical Association, 1995, 25:1277-81.
5. Oesterling JE et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. Journal of the American Medical Association, 1993, 270(7):860-4.
6. DeAntoni EP et al. Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study. Urology, 1996, 48(2):234-9.
7. Aragona F et al. Incidence of prostate cancer in Sicily: results of a multicenter case-findings protocol. European urology, 2005, 47(5):569-74.
8. Oesterling JE et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. British journal of urology, 1995, 75:347-53.
9. Weinrich MC et al. Reference ranges for serum prostate-specific antigen in black and white men without cancer. Urology, 1998, 52(6):967-73.
10. Henderson RJ et al. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer. National Cancer Institute, 1997, 89(2):134-8.
11. Abdalla I et al. Comparison of serum prostate-specific antigen levels and PSA density in African-American, white, and Hispanic men without prostate cancer. Urology, 1998, 51(2):300-5.
12. Eastham JA et al. Clinical characteristics and biopsy specimen features in African-American and white men without prostate cancer. Journal of the National Cancer Institute, 1998, 90(10):756-60.
13. Eastham JA et al. Racial variation in prostate specific antigen in a large cohort of men without prostate cancer. Journal of the Louisiana State Medical Society: official organ of the Louisiana State, 2001, 153(4):184-9.
14. Fowler JE Jr et al. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration and race. Cancer, 2001, 91(7):1291-6.